A detailed history of Bergan Kdv Wealth Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 460 shares of ZTS stock, worth $81,286. This represents 0.01% of its overall portfolio holdings.

Number of Shares
460
Previous 493 6.69%
Holding current value
$81,286
Previous $82,000 3.66%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$160.94 - $186.23 $5,311 - $6,145
-33 Reduced 6.69%
460 $79,000
Q1 2023

Apr 27, 2023

BUY
$145.48 - $175.02 $1,018 - $1,225
7 Added 1.44%
493 $82,000
Q4 2022

Jan 31, 2023

SELL
$131.14 - $157.47 $23,474 - $28,187
-179 Reduced 26.92%
486 $71,000
Q3 2022

Oct 24, 2022

SELL
$148.29 - $182.55 $17,349 - $21,358
-117 Reduced 14.96%
665 $99,000
Q2 2022

Jul 13, 2022

BUY
$155.97 - $200.09 $155 - $200
1 Added 0.13%
782 $134,000
Q1 2022

May 09, 2022

SELL
$181.39 - $234.03 $4,534 - $5,850
-25 Reduced 3.1%
781 $147,000
Q4 2021

Jan 28, 2022

BUY
$193.69 - $247.03 $4,842 - $6,175
25 Added 3.2%
806 $197,000
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $33,693 - $37,324
178 Added 29.52%
781 $152,000
Q4 2020

Feb 04, 2021

BUY
$157.07 - $174.35 $17,748 - $19,701
113 Added 23.06%
603 $100,000
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $199,329 - $253,845
-1,781 Reduced 78.42%
490 $67,000
Q1 2020

Apr 24, 2020

BUY
$92.66 - $144.94 $370 - $579
4 Added 0.18%
2,271 $267,000
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $1,743 - $1,998
15 Added 0.67%
2,267 $300,000
Q1 2019

May 09, 2019

BUY
$81.56 - $100.67 $146,155 - $180,400
1,792 Added 389.57%
2,252 $227,000
Q2 2018

Jul 23, 2018

BUY
$79.9 - $89.2 $36,754 - $41,032
460 New
460 $39,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bergan Kdv Wealth Management, LLC Portfolio

Follow Bergan Kdv Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.